GlassScriptPhysician profile
Christopher John Mcallister
NPI 1558532978
$6,583.27
in general payments reported to CMS, 2019-2025
38 companies · $877 in 2025
The $877 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $972 · 2020: $1,005 · 2021: $1,542 · 2022: $698 · 2023: $639 · 2024: $850 · 2025: $877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,366.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,585.62 | 2019-2025 | Proclaim, Eterna |
| Si-Bone, INC. | $438.55 | 2019-2024 | |
| Boston Scientific Corporation | $410.87 | 2021-2025 | Intracept, Intracept Rf Probe, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $308.60 | 2021-2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Nevro Corp. | $300.38 | 2019-2024 | Senza |
| Abbvie INC. | $248.69 | 2022-2025 | |
| Arbor Pharmaceuticals, INC. | $171.77 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $170.74 | 2020-2025 | Belbuca, Xtampza |
| Tersera Therapeutics LLC | $170.64 | 2022-2025 | Prialt |
| Scilex Pharmaceuticals INC. | $168.72 | 2019-2023 | Ztlido |
| Mdd US Operations, LLC | $168.17 | 2019-2020 | |
| Grt US Holding, INC. | $120.34 | 2019-2022 | |
| Vertos Medical, INC. | $114.72 | 2024 | Mild Device Kit |
| Globus Medical, INC. | $108.64 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $106.68 | 2020-2025 | Relistor |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $94.07 | 2020-2025 | Xcell |
| Zyla Life Sciences, INC. | $74.53 | 2019 | |
| Azurity Pharmaceuticals, INC. | $68.55 | 2023-2024 | Horizant, Horizant |
| Ibsa Pharma INC. | $68.05 | 2021-2024 | Tirosint, Licart |
| Teva Pharmaceuticals USA, INC. | $67.32 | 2019-2023 | Ajovy |
| Painteq LLC | $65.21 | 2023-2024 | Painteq |
| Merz Pharmaceuticals, LLC | $65.10 | 2023-2024 | Xeomin |
| Relievant Medsystems, INC. | $63.74 | 2021-2023 | Intracept |
| Allergan, INC. | $50.50 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $47.66 | 2019-2021 | |
| Almatica Pharma LLC | $43.83 | 2021-2022 | |
| Spr Therapeutics, INC | $36.65 | 2025 | Sprint Pns System |
| Valinor Pharma, LLC | $32.91 | 2025 | Movantik |
| Amgen INC. | $28.30 | 2019 | |
| Redhill Biopharma INC. | $26.88 | 2020 | |
| Depuy Synthes Sales INC. | $25.93 | 2025 | Orthovisc, Monovisc |
| Fidia Pharma USA INC. | $22.00 | 2023 | Hymovis, Triluron |
| Horizon Therapeutics Plc | $21.91 | 2020 | |
| Pfizer INC. | $21.09 | 2023 | |
| Averitas Pharma INC. | $18.46 | 2023 | Qutenza |
| Saluda Medical Americas, INC. | $18.07 | 2023 | Evoke Scs |
| Kowa Pharmaceuticals America, INC. | $16.66 | 2022 | |
| Medtronic USA, INC. | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Mcallister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.